pubmed-article:12652495 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C2825951 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C2348535 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C1515021 | lld:lifeskim |
pubmed-article:12652495 | lifeskim:mentions | umls-concept:C1546856 | lld:lifeskim |
pubmed-article:12652495 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:12652495 | pubmed:dateCreated | 2003-3-24 | lld:pubmed |
pubmed-article:12652495 | pubmed:abstractText | The present study prospectively evaluated adjunctive antiplatelet therapy in patients without insulin-requiring diabetes during elective coronary stenting. Three hundred patients were randomized to one of three treatment groups: clopidogrel pretreatment, adjunctive abciximab, or control. Stenting was successful in 98% and no deaths occurred. Thirty-day and 1-year major adverse coronary events (MACEs) was similar in all groups. A subgroup of 109 patients undergoing single-vessel stenting of type A/B1 lesions with short guidewire times had no postprocedure myocardial infarction or 30-day MACE. We conclude that patients with these characteristics may safely undergo elective coronary stenting without adjunctive antiplatelet therapy. | lld:pubmed |
pubmed-article:12652495 | pubmed:language | eng | lld:pubmed |
pubmed-article:12652495 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12652495 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12652495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12652495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12652495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12652495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12652495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12652495 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12652495 | pubmed:month | Apr | lld:pubmed |
pubmed-article:12652495 | pubmed:issn | 1522-1946 | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:MannTiftT | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:NewmanWilliam... | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:CubedduRobert... | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:RaynorLauraL | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:BowenJosieJ | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:SchneiderJoel... | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:RoseGregoryG | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:CubedduGabrie... | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:RazaJaffar... | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:JobeRobert... | lld:pubmed |
pubmed-article:12652495 | pubmed:author | pubmed-author:ZellingerMich... | lld:pubmed |
pubmed-article:12652495 | pubmed:copyrightInfo | Copyright 2003 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:12652495 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12652495 | pubmed:volume | 58 | lld:pubmed |
pubmed-article:12652495 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12652495 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12652495 | pubmed:pagination | 459-66 | lld:pubmed |
pubmed-article:12652495 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:meshHeading | pubmed-meshheading:12652495... | lld:pubmed |
pubmed-article:12652495 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12652495 | pubmed:articleTitle | Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive antiplatelet therapy. | lld:pubmed |
pubmed-article:12652495 | pubmed:affiliation | Wake Heart Center, Raleigh, North Carolina 27610, USA. wakeheartresearch@msn.com | lld:pubmed |
pubmed-article:12652495 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12652495 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12652495 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:12652495 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |